Middle-term therapeutic effect of the sacroiliac joint blockade in patients with lumbosacral fusion-related sacroiliac pain

Acta Orthop Traumatol Turc. 2014;48(1):61-6. doi: 10.3944/AOTT.2014.3190.

Abstract

Objective: The aim of this study was to compare the therapeutic effect of sacroiliac (SI) blockade in patients with and without lumbosacral fusion.

Methods: This study included 72 patients diagnosed with SI pain and who received blockade injection (methylprednisolone and lidocaine). Patients were divided into 2 groups; 22 patients in the fusion group who underwent previous lumbosacral fusion and 50 patients in the non-fusion group. Average follow-up was 17.7 (range: 6 to 30) months. All patients were evaluated before and after intervention using the Visual Analog Scale (VAS), Oswestry Disability Index, Rivermead Mobility Index and SF-36. Results were statistically analyzed.

Results: Activity pain (a component of VAS) was significantly better in the non-fusion group than the fusion group (p=0.042). No other statistically significant differences were observed between groups (p>0.05).

Conclusion: Sacroiliac blockade has a similar therapeutic effect on patients who underwent lumbosacral fusion surgery as on non-operated patients in the middle-term. Therefore, alternative treatment options are not necessary in patients with fusion.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Anti-Inflammatory Agents / administration & dosage*
  • Female
  • Health Status Indicators
  • Humans
  • Injections, Intra-Articular
  • Low Back Pain / etiology
  • Low Back Pain / therapy*
  • Male
  • Methylprednisolone / administration & dosage
  • Middle Aged
  • Nerve Block
  • Pain Measurement
  • Prospective Studies
  • Quality of Life
  • Sacroiliac Joint*
  • Spinal Fusion / adverse effects*

Substances

  • Anti-Inflammatory Agents
  • Methylprednisolone